Brii Biosciences Limited (7SS) — Defensive Interval Ratio
Brii Biosciences Limited (7SS) has a Defensive Interval Ratio of 15053 days as of December 2025. Defensive assets of €1.33 Billion (cash €-, short-term investments €1.33 Billion, receivables €-) cover 15053 days of daily cash needs of €88.53K/day. See 7SS working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
Brii Biosciences Limited Defensive Interval Ratio (2020–2025)
This chart shows how Brii Biosciences Limited's Defensive Interval Ratio has evolved across 6 annual periods from 2020 to 2025. As of December 2025, the ratio stands at 15053 days, meaning defensive assets of €1.33 Billion can fund 15053 days of operations without new revenue. See Brii Biosciences Limited balance sheet independence to measure how much of total assets are equity-financed.
Annual Defensive Interval Ratio for Brii Biosciences Limited (2020–2025)
The table below presents the year-by-year Defensive Interval Ratio for Brii Biosciences Limited from 2020 to 2025, covering 6 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see 7SS company net worth.
| Year | DIR (days) | Defensive Assets (EUR) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2025 | 15053 days | €1.33 Billion | €88.53K/day | €- | €1.33 Billion | ▲ +8844 days |
| 2024 | 6209 days | €1.32 Billion | €212.11K/day | €- | €1.32 Billion | ▼ -87 days |
| 2023 | 6296 days | €2.17 Billion | €344.85K/day | €- | €2.17 Billion | ▲ +3417 days |
| 2022 | 2878 days | €1.81 Billion | €627.71K/day | €- | €1.81 Billion | ▲ +2229 days |
| 2021 | 650 days | €499.65 Million | €769.08K/day | €- | €499.65 Million | ▲ +637 days |
| 2020 | 13 days | €20.00 Million | €1.58 Million/day | €- | €20.00 Million | — |